Cargando…
FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE
Introduction: Pentavalent antimonials are the first drug of choice in the treatment of tegumentary leishmaniasis. Data on ototoxicity related with such drugs is scarcely available in literature, leading us to develop a study on cochleovestibular functions. Case Report: A case of a tegumentary leishm...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto de Medicina Tropical
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172117/ https://www.ncbi.nlm.nih.gov/pubmed/25229226 http://dx.doi.org/10.1590/S0036-46652014000500012 |
_version_ | 1782336009072017408 |
---|---|
author | Valete-Rosalino, Cláudia Maria Araujo-Melo, Maria Helena Bezerra, Débora Cristina de Oliveira de Barcelos, Renata Oliveira de Melo-Ferreira, Vanessa Torraca, Tânia Salgado de Sousa Martins, Ana Cristina da Costa Moreira, João Soares Vargas, Mirian Catherine Melgares Braga, Frederico Pereira Bom Salgueiro, Mariza de Matos Saheki, Maurício Naoto Schubach, Armando Oliveira |
author_facet | Valete-Rosalino, Cláudia Maria Araujo-Melo, Maria Helena Bezerra, Débora Cristina de Oliveira de Barcelos, Renata Oliveira de Melo-Ferreira, Vanessa Torraca, Tânia Salgado de Sousa Martins, Ana Cristina da Costa Moreira, João Soares Vargas, Mirian Catherine Melgares Braga, Frederico Pereira Bom Salgueiro, Mariza de Matos Saheki, Maurício Naoto Schubach, Armando Oliveira |
author_sort | Valete-Rosalino, Cláudia Maria |
collection | PubMed |
description | Introduction: Pentavalent antimonials are the first drug of choice in the treatment of tegumentary leishmaniasis. Data on ototoxicity related with such drugs is scarcely available in literature, leading us to develop a study on cochleovestibular functions. Case Report: A case of a tegumentary leishmaniasis patient, a 78-year-old man who presented a substantial increase in auditory threshold with tinnitus and severe rotatory dizziness during the treatment with meglumine antimoniate, is reported. These symptoms worsened in two weeks after treatment was interrupted. Conclusion: Dizziness and tinnitus had already been related to meglumine antimoniate. However, this is the first well documented case of cochlear-vestibular toxicity related to meglumine antimoniate. |
format | Online Article Text |
id | pubmed-4172117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Instituto de Medicina Tropical |
record_format | MEDLINE/PubMed |
spelling | pubmed-41721172014-10-28 FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE Valete-Rosalino, Cláudia Maria Araujo-Melo, Maria Helena Bezerra, Débora Cristina de Oliveira de Barcelos, Renata Oliveira de Melo-Ferreira, Vanessa Torraca, Tânia Salgado de Sousa Martins, Ana Cristina da Costa Moreira, João Soares Vargas, Mirian Catherine Melgares Braga, Frederico Pereira Bom Salgueiro, Mariza de Matos Saheki, Maurício Naoto Schubach, Armando Oliveira Rev Inst Med Trop Sao Paulo Case Report Introduction: Pentavalent antimonials are the first drug of choice in the treatment of tegumentary leishmaniasis. Data on ototoxicity related with such drugs is scarcely available in literature, leading us to develop a study on cochleovestibular functions. Case Report: A case of a tegumentary leishmaniasis patient, a 78-year-old man who presented a substantial increase in auditory threshold with tinnitus and severe rotatory dizziness during the treatment with meglumine antimoniate, is reported. These symptoms worsened in two weeks after treatment was interrupted. Conclusion: Dizziness and tinnitus had already been related to meglumine antimoniate. However, this is the first well documented case of cochlear-vestibular toxicity related to meglumine antimoniate. Instituto de Medicina Tropical 2014 /pmc/articles/PMC4172117/ /pubmed/25229226 http://dx.doi.org/10.1590/S0036-46652014000500012 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Valete-Rosalino, Cláudia Maria Araujo-Melo, Maria Helena Bezerra, Débora Cristina de Oliveira de Barcelos, Renata Oliveira de Melo-Ferreira, Vanessa Torraca, Tânia Salgado de Sousa Martins, Ana Cristina da Costa Moreira, João Soares Vargas, Mirian Catherine Melgares Braga, Frederico Pereira Bom Salgueiro, Mariza de Matos Saheki, Maurício Naoto Schubach, Armando Oliveira FIRST REPORT ON OTOTOXICITY OF MEGLUMINE ANTIMONIATE |
title | FIRST REPORT ON OTOTOXICITY OF MEGLUMINE
ANTIMONIATE |
title_full | FIRST REPORT ON OTOTOXICITY OF MEGLUMINE
ANTIMONIATE |
title_fullStr | FIRST REPORT ON OTOTOXICITY OF MEGLUMINE
ANTIMONIATE |
title_full_unstemmed | FIRST REPORT ON OTOTOXICITY OF MEGLUMINE
ANTIMONIATE |
title_short | FIRST REPORT ON OTOTOXICITY OF MEGLUMINE
ANTIMONIATE |
title_sort | first report on ototoxicity of meglumine
antimoniate |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172117/ https://www.ncbi.nlm.nih.gov/pubmed/25229226 http://dx.doi.org/10.1590/S0036-46652014000500012 |
work_keys_str_mv | AT valeterosalinoclaudiamaria firstreportonototoxicityofmeglumineantimoniate AT araujomelomariahelena firstreportonototoxicityofmeglumineantimoniate AT bezerradeboracristinadeoliveira firstreportonototoxicityofmeglumineantimoniate AT debarcelosrenataoliveira firstreportonototoxicityofmeglumineantimoniate AT demeloferreiravanessa firstreportonototoxicityofmeglumineantimoniate AT torracataniasalgadodesousa firstreportonototoxicityofmeglumineantimoniate AT martinsanacristinadacosta firstreportonototoxicityofmeglumineantimoniate AT moreirajoaosoares firstreportonototoxicityofmeglumineantimoniate AT vargasmiriancatherinemelgares firstreportonototoxicityofmeglumineantimoniate AT bragafredericopereirabom firstreportonototoxicityofmeglumineantimoniate AT salgueiromarizadematos firstreportonototoxicityofmeglumineantimoniate AT sahekimauricionaoto firstreportonototoxicityofmeglumineantimoniate AT schubacharmandooliveira firstreportonototoxicityofmeglumineantimoniate |